Loading people...
Jui Tan is a General Partner at BlueRun Ventures, a prominent early-stage venture capital firm. They are known for their expertise in identifying and investing in innovative technology startups.
Jui Tan primarily invests in early-stage technology companies across sectors such as enterprise software, artificial intelligence, and transformative consumer platforms. They seek visionary founders with disruptive ideas.
Jui Tan works as a General Partner at BlueRun Ventures, a leading venture capital firm focused on early-stage technology investments.
Jui Tan stands as a distinguished General Partner at BlueRun Ventures, a leading venture capital firm renowned for its strategic early-stage investments in groundbreaking technology companies. In this pivotal role, Tan is instrumental in shaping the firm's investment thesis, identifying promising startups, and providing crucial guidance to portfolio companies. Their work at BlueRun Ventures involves a deep dive into emerging markets and technological advancements, aiming to unearth the next generation of industry leaders.
Tan's investment focus at BlueRun Ventures spans a diverse range of high-growth sectors. They are particularly keen on enterprise software solutions that drive efficiency and innovation for businesses, artificial intelligence applications that redefine industries, and consumer technology platforms that enhance daily life. Jui Tan seeks out companies demonstrating strong product-market fit, scalable business models, and, most importantly, visionary founding teams with the ambition to disrupt established markets. Their approach emphasizes long-term partnership, offering not just capital but also strategic insights, operational expertise, and extensive network access to accelerate startup growth.
Prior to their tenure at BlueRun Ventures, Jui Tan built a robust career foundation that equipped them with a unique perspective on technology and entrepreneurship. With a background rooted in both technical innovation and strategic business development, Tan has held significant roles that involved scaling technology products and leading high-performing teams. This experience provided invaluable insights into the challenges and opportunities faced by startups, fostering a deep empathy for founders and a keen eye for operational excellence. Their journey into venture capital was a natural progression, driven by a passion for empowering innovators and contributing to the creation of impactful technologies.
While specific individual investments are often part of BlueRun Ventures' collective portfolio strategy, Jui Tan is known for championing companies that exhibit significant potential for market transformation. They are consistently on the lookout for ventures that leverage cutting-edge technology to solve complex problems or unlock new market opportunities. Tan's commitment extends beyond capital deployment; they actively engage with founders, offering mentorship and strategic counsel to navigate the complexities of startup growth, fundraising, and market expansion. Their dedication to fostering innovation makes Jui Tan a sought-after partner for ambitious entrepreneurs seeking to build enduring companies. This strategic involvement underscores BlueRun Ventures' reputation as a founder-friendly firm committed to long-term success.
Jui Tan is the Managing Partner at Lanchi Ventures, formerly known as BlueRun Ventures China and BRV Aster, based in Beijing, China. Before transitioning to the venture capital industry in March 2001, he served as the Director of Global Service Development at Singapore Telecom and held engineering management positions at IBM. He earned a Bachelor of Science in Electrical and Electronics Engineering from Nanyang Technological University and an MBA from IMD in Switzerland. Recognized as a top global investor on the 2023 Forbes Midas List, Tan has backed numerous prominent technology companies, including Li Auto, Moonshot AI, Genspark, and WeDoctor. Throughout his twenty-year tenure at the firm, he has guided multiple portfolio companies to successful public offerings. His current focus centers on early-stage investments across artificial intelligence, deep technology, enterprise software, and digital healthcare.
